These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. Kubota A; Yamada Y; Kagimoto S; Shimatsu A; Imamura M; Tsuda K; Imura H; Seino S; Seino Y J Clin Invest; 1994 Mar; 93(3):1321-5. PubMed ID: 8132773 [TBL] [Abstract][Full Text] [Related]
4. Clinical relevance of the expression of somatostatin receptors in digestive endocrine tumours. Capurso G; Panzuto F; Delle Fave G Dig Liver Dis; 2010 Mar; 42(3):173-4. PubMed ID: 20117969 [No Abstract] [Full Text] [Related]
5. Somatostatin receptor subtypes 2 and 5 are associated with better survival in well-differentiated endocrine carcinomas. Corleto VD; Falconi M; Panzuto F; Milione M; De Luca O; Perri P; Cannizzaro R; Bordi C; Pederzoli P; Scarpa A; Delle Fave G Neuroendocrinology; 2009; 89(2):223-30. PubMed ID: 18974627 [TBL] [Abstract][Full Text] [Related]
6. Somatostatin and its receptor family. Patel YC Front Neuroendocrinol; 1999 Jul; 20(3):157-98. PubMed ID: 10433861 [TBL] [Abstract][Full Text] [Related]
7. Differential expression of five somatostatin receptor subtypes, SSTR1-5, in the CNS and peripheral tissue. Raulf F; Pérez J; Hoyer D; Bruns C Digestion; 1994; 55 Suppl 3():46-53. PubMed ID: 7698537 [TBL] [Abstract][Full Text] [Related]
10. [The somatostatin receptor family--a window against new diagnosis and therapy of cancer]. Hofsli E Tidsskr Nor Laegeforen; 2002 Feb; 122(5):487-91. PubMed ID: 11961977 [TBL] [Abstract][Full Text] [Related]
11. The role of somatostatin and dopamine D2 receptors in endocrine tumors. Gatto F; Hofland LJ Endocr Relat Cancer; 2011 Dec; 18(6):R233-51. PubMed ID: 22135243 [TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical localization of somatostatin receptor subtypes in benign and malignant adrenal tumours. Unger N; Serdiuk I; Sheu SY; Walz MK; Schulz S; Saeger W; Schmid KW; Mann K; Petersenn S Clin Endocrinol (Oxf); 2008 Jun; 68(6):850-7. PubMed ID: 18031328 [TBL] [Abstract][Full Text] [Related]
13. A single amino acid substitution in somatostatin receptor subtype 5 increases affinity for somatostatin-14. Ozenberger BA; Hadcock JR Mol Pharmacol; 1995 Jan; 47(1):82-7. PubMed ID: 7838136 [TBL] [Abstract][Full Text] [Related]
14. Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors. Hofland LJ; De Herder WW; Visser-Wisselaar HA; Van Uffelen C; Waaijers M; Zuyderwijk J; Uitterlinden P; Kros MJ; Van Koetsveld PM; Lamberts SW J Clin Endocrinol Metab; 1997 Sep; 82(9):3011-8. PubMed ID: 9284735 [TBL] [Abstract][Full Text] [Related]
15. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Raynor K; Murphy WA; Coy DH; Taylor JE; Moreau JP; Yasuda K; Bell GI; Reisine T Mol Pharmacol; 1993 Jun; 43(6):838-44. PubMed ID: 8100350 [TBL] [Abstract][Full Text] [Related]
16. Somatostatin receptor subtype gene expression in pituitary adenomas. Miller GM; Alexander JM; Bikkal HA; Katznelson L; Zervas NT; Klibanski A J Clin Endocrinol Metab; 1995 Apr; 80(4):1386-92. PubMed ID: 7714115 [TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor subtypes 2 and 5 mediate inhibition of egg yolk-induced gall bladder emptying in mice. Kaczmarek P; Singh V; Cashen DE; Yang L; Berk S; Pasternak A; Xiong Y; Shen DM; Hutchins SM; Chapman K; Wiedenmann B; Schaeffer JM; Strowski MZ Neurogastroenterol Motil; 2010 Feb; 22(2):204-9, e66. PubMed ID: 19754922 [TBL] [Abstract][Full Text] [Related]